Clinical Trial Update: Phase I Study of BM2216 ER vs. Melogabalin Besilate: Safety, PK, and Food Effect in Healthy Adults [Phase 1]

View source ↗

Summary

This Phase I study evaluated the safety, pharmacokinetics, and food effect of BM2216 ER compared with Melogabalin Besilate in healthy adults, with the trial com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Neuropathy

Drugs mentioned

• BM2216 ER
• Melogabalin Besilate (melogabalin besilate)

Snippet

Sponsor: Zhejiang Anglikang Pharmaceutical Co., Ltd. | Conditions: Diabetic Neuropathies, Diabetes Mellitus | Phase 1 | Status: COMPLETED